AA
AlphaCentric Advisors’s VYNE Therapeutics VYNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-268,485
| Closed | -$505K | – | 286 |
|
|
2024
Q3 | $505K | Sell |
268,485
-42,015
| -14% | -$79K | 0.38% | 74 |
|
|
2024
Q2 | $612K | Sell |
310,500
-134,500
| -30% | -$265K | 0.45% | 71 |
|
|
2024
Q1 | $1.37M | Sell |
445,000
-223,151
| -33% | -$685K | 0.82% | 47 |
|
|
2023
Q4 | $1.56M | Buy |
+668,151
| New | +$1.56M | 1.05% | 32 |
|